Ultragenyx Pharmaceutical Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
92.89
|
|
Average Rating
|
4.37
|
|
# Strong Buys
|
10
|
|
# Buys
|
6
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.81
|
-3.50
|
-1.69
|
-93.37%
|
|
2022-06-30
|
-1.75
|
-2.26
|
-0.51
|
-29.14%
|
|
2022-03-31
|
-1.76
|
-2.19
|
-0.43
|
-24.43%
|
|
2021-12-31
|
-1.34
|
-1.79
|
-0.45
|
-33.58%
|
|
2021-09-30
|
-1.41
|
-1.08
|
0.33
|
23.40%
|
|
2021-06-30
|
-1.33
|
-1.81
|
-0.48
|
-36.09%
|
|
2021-03-31
|
-1.24
|
-2.03
|
-0.79
|
-63.71%
|
|
2020-12-31
|
-1.15
|
-0.37
|
0.78
|
67.83%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-7.95
|
|
2021-12-31
|
-6.71
|
|
2020-12-31
|
-3.14
|
|
2019-12-31
|
-7.12
|
|
2018-12-31
|
-3.91
|
|
2017-12-31
|
-7.11
|
|
2016-12-31
|
-6.20
|
|
2015-12-31
|
-3.91
|
|
2014-12-31
|
-2.32
|
|
2013-12-31
|
-4.98
|